Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06595836 · ClinicalTrials.gov registry record · NA
Evaluation of the Performance and Acceptability of a Synthetic Polyisoprene Male Condom Compared to a Natural Rubber Latex Condom
A NA study of Condom Use, sponsored by Thai Nippon Rubber Industry Public Company Limited.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 2
- Study locations
NCT06595836: Recruiting NA study of Condom Use, sponsored by Thai Nippon Rubber Industry Public Company Limited.
NCT06595836 is a NA study of Condom Use that is actively recruiting participants, run by Thai Nippon Rubber Industry Public Company Limited. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06595836, a NA study of Condom Use, is actively recruiting participants, sponsored by Thai Nippon Rubber Industry Public Company Limited.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is a masked (investigators, research staff), two-way crossover, randomized to sequence of use study designed to evaluate the acceptability and functional performance (breakage, slippage) of a silicone lubricated polyisoprene condom and a silicone lubricated natural rubber latex condom.
Primary Outcome
The total clinical failure rate is defined as the number of condoms that broke or slipped completely off the penis during intercourse or withdrawal over the number of condoms used for vaginal intercourse.
Conditions Studied
Interventions
- DEVICE Silicone Lubricated Synthetic polyisoprine condom
- DEVICE Silicone Lubricated Natural Rubber Latex Condom
Study Locations (2)
California
- Essential Access - Berkeley
- Essential Access - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-01-02 |
| Est. Completion | 2025-02-28 |
| Phase | NA |
What NCT06595836 shows while recruiting
NCT06595836 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Condom Use appearing as the primary indexed condition, and to 2 interventions - of which Silicone Lubricated Synthetic polyisoprine condom is the first listed.
NCT06595836 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06595836 about?
NCT06595836 is a clinical study titled "Evaluation of the Performance and Acceptability of a Synthetic Polyisoprene Male Condom Compared to a Natural Rubber Latex Condom". This study is a masked (investigators, research staff), two-way crossover, randomized to sequence of use study designed to evaluate the acceptability and functional performance (breakage, slippage) of a silicone lubricated polyisoprene condom and a silicone lubricated natural rubber latex condom.
What is the current status of trial NCT06595836?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-01-02. Estimated completion is 2025-02-28.
What conditions does trial NCT06595836 study?
This clinical trial studies the following conditions: Condom Use.
What interventions are being tested in trial NCT06595836?
The interventions under investigation include: Silicone Lubricated Synthetic polyisoprine condom (DEVICE), Silicone Lubricated Natural Rubber Latex Condom (DEVICE).
Who is sponsoring clinical trial NCT06595836?
This trial is sponsored by Thai Nippon Rubber Industry Public Company Limited, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06595836 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06595836's enrollment target sits among peer trials
300 330th of 2000 higher than 1,631 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI